Table 2 Distribution of ApoE polymorphism among gastric cancer cases and controls
Cases ‡ | Controls^ | All cases | Intestinal (n=79) | Diffuse (n=57) | |
|---|---|---|---|---|---|
n (%) | n (%) | OR (95% CI)† | OR (95% CI)† | OR (95% CI)† | |
ε3/ε3 | 109 (71.71) | 253 (62.94) | 1* | 1* | 1* |
ε3/ε2 | 15 (9.87) | 63 (15.67) | 0.43 (0.21 -0.91) | 0.34 (0.13 – 0.92) | 0.57 (0.23 – 1.40) |
ε3/ε4 | 27 (17.76) | 75 (18.66) | 0.70 (0.37 - 1.30) | 0.75 (0.35 – 1.60) | 0.64 (0.27 – 1.47) |
ε2/ε2 | 0 (0.00) | 5 (1.24) | NC | NC | NC |
ε2/ε4 | 1 (0.66) | 5 (1.24) | 1.25 (0.10 - 15.10) | 2.54 (0.21 – 31.17) | NC |
ε4/ε4 | 0 (0.00) | 1 (0.25) | NC | NC | NC |
ε3/ε2 or ε2/ε2 | 15 (12.10) | 68 (21.18) | 0.40 (0.19 - 0.84) | 0.31 (0.11 – 0.83) | 0.53 (0.21 – 1.30) |
ε3/ε4 or ε4/ε4 | 27 (19.85) | 76 (23.10) | 0.68 (0.36 - 1.26) | 0.71 (0.34 – 1.53) | 0.62 (0.27 – 1.43) |